WEBVTT 00:00.000 --> 00:21.000 Test 1-2 testing 1-2 test test 1-2 testing test 1-2 test 01:30.920 --> 01:42.700 Gonna try and pack this all in in about a half an hour, because Mark is coming on at 8, and so I don't wanna get it his way, I'm just gonna kind of be a pre-show and give that the voice just a little bit of a rest 01:42.700 --> 01:59.700 The schedule for 16 minutes next is going on French, British, Italian, Japanese television. 01:59.700 --> 02:02.700 People everywhere are starting to listen to him. 02:02.700 --> 02:07.700 It's embarrassing. 02:07.700 --> 02:09.700 Kids deserve a lot of credit. 02:09.700 --> 02:12.700 This town's been flooded with phony twenties for weeks. 02:12.700 --> 02:14.700 Oh, it was nothing, really. 02:14.700 --> 02:20.700 But old Mr. Pietro posing as a doorman sure had us fooled for a while. 02:20.700 --> 02:24.700 He really gave himself away when he put on his little puppet show for us. 02:24.700 --> 02:26.700 The real hero of Scooby-Doo. 02:26.700 --> 02:29.700 By the way, where is he? 02:29.700 --> 02:32.700 Oh, no. Look at him. 02:32.700 --> 02:37.700 Like I said before, what a ham. 02:37.700 --> 02:42.700 Whoopee, whoopee, whoopee, whoop. 02:42.700 --> 02:47.700 God damn tea was too hot. I just burnt my throat. Dang it. 02:47.700 --> 03:08.700 Hello, everybody. Welcome to the show. Good to see you guys here. Thanks for joining me again tonight. 03:08.700 --> 03:14.700 Sound just a little scratchy, but I guess it's just something I'm going to get out of my throat here. 03:14.700 --> 03:19.700 No problems. 03:19.700 --> 03:25.700 I slept like a million dollars last night, which was just spectacular. 03:25.700 --> 03:29.700 If anything, my voice is a little bit lower today than it was yesterday. 03:29.700 --> 03:36.700 This is Gigo in biological and high-resistance local information free on how to stand my hours. 03:36.700 --> 03:41.700 2023, 22 of October. 03:41.700 --> 03:50.700 And we are still trying to fight through this limited spectrum of bait, which we have been trapped in by TV and social media. 03:50.700 --> 03:58.700 And we're still trying to make what is perceived to be true, actually true, Gigo's in general. 03:58.700 --> 04:03.700 Because as of right now, we're still misleadingly young, and that's going to lead to disaster. 04:03.700 --> 04:06.700 We don't fix that real soon. 04:06.700 --> 04:11.700 But they've been doing it to us for a while, right? That's why we all fell for it. 04:11.700 --> 04:20.700 And so anybody can come to life. It's never too late. 04:20.700 --> 04:26.700 And so we've got to make sure that our family and friends understand that it's not too late to admit that, you know, 04:26.700 --> 04:30.700 something screwy is going on and I should have known better. 04:30.700 --> 04:41.700 But it's getting more and more obvious that people have to actively ignore what's going on otherwise it's just obvious. 04:56.700 --> 05:06.700 So yeah, welcome to the show. Welcome to the show. 05:06.700 --> 05:16.700 We're going to do a short one tonight because, like I said, although I think I'm firing on all cylinders more or less, 05:16.700 --> 05:19.700 it still feels a little alien. 05:19.700 --> 05:24.700 And it still feels like I should be a little more careful. 05:25.700 --> 05:35.700 And so I'm not sure what to say about the obvious sort of settling in at an even slightly lower octave than yesterday. 05:35.700 --> 05:43.700 But it's been pretty consistent all day. And in fact, when I woke up this morning, if you can believe it, it was even lower than this. 05:44.700 --> 05:55.700 I don't know what to say. It's still, it's pretty close to the original instrument, but, you know, obviously things happened in my larnix or voice box or whatever. 05:55.700 --> 06:02.700 And so, yeah, we're just going to keep playing it by ear. I'm not, I don't feel like I'm stressing it at all. 06:02.700 --> 06:06.700 So it's, you know, just, I'm just going with it. 06:07.700 --> 06:12.700 Yeah, it was obviously inflamed. It was obvious. I mean, there's all kinds of things wrong with it. 06:12.700 --> 06:15.700 But now, I don't know, I'm just trying to keep my throat clean. 06:15.700 --> 06:20.700 I've been gargling some kind of colloidal silver mouthwash. 06:20.700 --> 06:27.700 I've been, you know, trying to brush my teeth a couple times a day, which I normally do, but now a little bit more vigilantly maybe. 06:27.700 --> 06:35.700 I don't know. I don't know what to do. I'm just trying to play it by ear and keep thinking because I'm definitely thankful. 06:36.700 --> 06:49.700 So don't take the bait on TV and social media. That's been our message for a long time now. And it is this Scooby-Doo mystery that they're still trying to get us to solve. 06:49.700 --> 07:03.700 And so, as we approach Halloween and then more importantly, Thanksgiving, when a lot of us are going to come together with our family and friends, it would be really good for us to have some, let's say, talking points ready to go. 07:03.700 --> 07:07.700 And so I'm kind of interested in input on that perspective. 07:07.700 --> 07:19.700 So if you, you know, you're that emailing type or you got an opinion that you always wanted to share in the next couple weeks, it might be a good idea because I think this is, this is one of those thanksgivings where a lot of progress might be made. 07:19.700 --> 07:22.700 So that's my hope. 07:22.700 --> 07:31.700 There are all these books that are out there that people might be talking about as they sit at your, you know, your, your dinner table. 07:31.700 --> 07:34.700 And so it might be good to already have something to talk about. 07:34.700 --> 07:38.700 And then this book apparently is going to come out on December 5th of course. 07:38.700 --> 07:42.700 I imagine it's going to be pushed back even farther because that's how this clown show goes. 07:42.700 --> 07:50.700 But hopefully it will be December 5th and so that we can, you know, make some progress from that, that sort of spiking of the football there. 07:51.700 --> 07:58.700 We're still trying to, I'm still trying to teach everybody that these people have been put into place. 07:58.700 --> 08:01.700 They were put in place a long time ago. 08:01.700 --> 08:03.700 I guess I get this music out of here. 08:03.700 --> 08:05.700 They were put in place a long time ago. 08:05.700 --> 08:09.700 And it's not something that a lot of us have been aware of for a long time. 08:09.700 --> 08:13.700 I mean, I, at one point during the pandemic. 08:14.700 --> 08:27.700 Thought that it was a borderline miracle that I finally got in touch with Brett Weinstein and that I was on a signal chat with him made it seem so like, you know, progress was really being made. 08:28.700 --> 08:30.700 And that's in the end. 08:30.700 --> 08:41.700 What we're, what we're dealing with here is that this is the control mechanism by which that Noam Chomsky quote in the beginning there is really executed this limited spectrum of debate. 08:41.700 --> 08:52.700 But then a lively discussion within that limited spectrum to make people think that there's a real genuine resistance, a genuine dissident, you know, opinion. 08:52.700 --> 08:57.700 And that's what this intellectual dark web does in a nutshell. 08:57.700 --> 09:10.700 And it's interesting to note that that that intellectual dark web was put in place around 2018 or 2019 largely by people like Elon Musk and Peter Teal. 09:11.700 --> 09:19.700 And then we now know that Peter Teal is invested in this antibody patent paradox to the hilt. 09:19.700 --> 09:23.700 It just becomes obvious that this is the story right here. 09:23.700 --> 09:34.700 The only question is, are we, am I fooling myself into thinking that what's on this screen is somehow revolutionary rather than exactly what they want. 09:34.700 --> 09:55.700 Because maybe the idea is to tear down the old system to expose it as garbage, but to play a shell game and get everybody to accept the idea that MRNA is a wonderful next generation replacement for this previously misguided intramuscular injection methodology. 09:56.700 --> 10:01.700 That's a distinct possibility that I don't dismiss lightly. 10:01.700 --> 10:03.700 And in fact, I don't dismiss at all. 10:03.700 --> 10:15.700 And I'm still trying to check myself to make sure that I'm not really just a puppet already here leading the charge to burn it all down or something like that, which is not really what I mean. 10:15.700 --> 10:19.700 But with regard to the vaccine schedule, I basically mean that. 10:20.700 --> 10:22.700 Let me see. 10:22.700 --> 10:23.700 Do I have this set up correctly? 10:23.700 --> 10:25.700 I think I do. 10:25.700 --> 10:29.700 So this illusion of consensus is what we're trying to break. 10:29.700 --> 10:31.700 It's these people that we're trying to pin down. 10:31.700 --> 10:35.700 And I'm going to continue to work on that on and off for the coming weeks. 10:35.700 --> 10:45.700 But right now, I think it's better for my voice and us that we do more of these study halls for the next couple weeks where, where maybe I'll take some notes. 10:45.700 --> 10:46.700 Maybe I won't depending on what it is. 10:46.700 --> 10:49.700 I'll just stop and talk about some of the things that are here. 10:49.700 --> 10:51.700 And tonight I have a very last night. 10:51.700 --> 10:52.700 Sorry. 10:52.700 --> 10:53.700 We had this. 10:53.700 --> 10:59.700 We had this show with with Annie DeGroote. 10:59.700 --> 11:03.700 And actually, that should be. 11:03.700 --> 11:04.700 Yeah, it should be root. 11:04.700 --> 11:05.700 Groot. 11:06.700 --> 11:11.700 And it's DeGroote, I think. 11:11.700 --> 11:16.700 And in Dutch, you would say, oh, long old for that. 11:16.700 --> 11:17.700 So that's DeGroote. 11:17.700 --> 11:18.700 Why? 11:18.700 --> 11:23.700 I haven't said a Dutch word since I broke my throat. 11:23.700 --> 11:25.700 So that's weird because that's actually back there. 11:25.700 --> 11:26.700 DeGroote. 11:26.700 --> 11:28.700 And now I can say. 11:28.700 --> 11:38.700 Anyway, Annie DeGroote is the leader of this epivax company. 11:38.700 --> 11:49.700 And so we were trying to, I was trying to take a little bit out of this talk about T-cell epitopes and a little bit about general immunology that I have been talking about before. 11:49.700 --> 11:53.700 That the T-cell epitopes were actually important, that they would actually look for them. 11:53.700 --> 12:07.700 And that there was this possibility that they would use T-cell epitopes planted in a biologic to sort of up or down, you know, up regulate the immunogenicity of an otherwise non-immunogenic protein. 12:07.700 --> 12:22.700 And so they could have done that with a coronavirus spike protein, which may not be very immunogenic because it has overlap with human sequences, which she showed in that discussion to be actually tolerogenic. 12:22.700 --> 12:28.700 So coronavirus proteins, especially the spike proteins, are designed to be tolerogenic. 12:28.700 --> 12:51.700 So if you wanted to make a coronavirus spike protein, one of the ways to do it, an epivax technology would have definitely been a way to do it, would be to take one of these or more of these small epitopes and insert them into a spike protein and then claim that this was the spike protein that you found on this novel coronavirus so that when you used it as an immunogen, it would already work. 12:52.700 --> 13:04.700 One of the other possibilities, of course, is to insert some novel sequence into the spike protein of the vaccine that you took, that you're basing on the viral protein. 13:04.700 --> 13:09.700 And either way, you would be doing the same thing, but it's ultra clever, right? 13:09.700 --> 13:15.700 If you put it in the wild sequence, and then when it's in the wild sequence, you just kind of shrug your shoulders. 13:15.700 --> 13:23.700 Well, guess it's there, even though all along, you knew that you had already designed it to have many of those epitopes and to be highly immunogenic. 13:23.700 --> 13:35.700 So that's one of those things where, again, this is where I tend to agree with people like Kevin McCarron because this is a very, was a fine line. 13:35.700 --> 13:44.700 And she was showing you this hot scale of almost like a skull ball rating of peppers, but she was looking at immunogenicity of proteins. 13:44.700 --> 13:54.700 And then talking about these small T cell epitopes and the more of them that there were, the higher on the immunogenicity scale, these proteins showed up. 13:54.700 --> 14:02.700 So that's extraordinary because then the next step there is, of course, can you make proteins that are more immunogenic? 14:02.700 --> 14:09.700 And her answer, of course, would be, who's asking? And if it was the DOD, she would say, absolutely, I can. 14:09.700 --> 14:23.700 And so here again, you just got to understand that although they have this technology deploying, it still would require recombinant DNA to make the RNA, and then that RNA would essentially be a clone, right? 14:23.700 --> 14:26.700 Because that's how you would do it. You've got to make it perfect. 14:26.700 --> 14:41.700 So there's, or the protein from it. But anyway, I wanted to watch this video because this video is another dude that works for Abselara, but he does the machine learning. 14:41.700 --> 14:52.700 And it's a short video. I can get it done by eight. And I'm going to stop it before it's all the way done because I really want to do is just get to the technology that they use to sort through these cells. 14:52.700 --> 14:56.700 So you can see the basic methodology isn't that magical. 14:56.700 --> 15:07.700 And then you can see really how actually it's possible that these guys just came together because of this microfluidics technology. 15:07.700 --> 15:15.700 And, I mean, glow on the dark beads and stuff like that is so basic technology that they use. It's actually quite extraordinary. 15:16.700 --> 15:28.700 And in a way, it's foolproof, but also, you know, you see again why all this talk that we've watched a couple of lectures of these people now. 15:28.700 --> 15:35.700 And they make these grave, great excuse me, grand statements about what they can accomplish and what they can do. 15:35.700 --> 15:42.700 And they have all this jargon and stuff. But in the end, it's just little tiny single cell wells that they're able to fill with single cells. 15:42.700 --> 15:46.700 There's little beads in there and there's some fluorescence and it's not really that clever. 15:46.700 --> 15:52.700 And that's, you know, maybe sounds arrogant from my perspective or from your perspective for me to say that. 15:52.700 --> 16:11.700 But I just, I don't want, I want, what I want you to see is that actually the technology to make that little container with microfluidic chambers is more important to this than the beads because the beads, I mean, it's, we're going to explain it when we listen to it. 16:11.700 --> 16:18.700 Let's just do that now. 16:18.700 --> 16:26.700 And I will shrink my head. 16:26.700 --> 16:32.700 I'm Fabius and I joined a seller six months ago and I'm now leading the machine learning team. 16:32.700 --> 16:35.700 My background is machine learning and software engineering. 16:35.700 --> 16:44.700 Before, I spent 10 years on Google speech recognition team, followed by another two years at Google health, working on computer vision for radiology. 16:44.700 --> 16:54.700 So first, here's a disclaimer about this talk. I'll give you a few seconds to read it over. This is from our lawyers. 16:54.700 --> 16:57.700 Next, my plan for today is to tell you about a seller is technology platform. 16:57.700 --> 17:06.700 Oh, so that, that part, just so you know that I didn't miss it, that part was just something where he, he has this statement up here that said this presentation contains forward looking statements. 17:06.700 --> 17:15.700 So he's just, he's basically saying that we're making a bunch of predictions, but as a result, the forward looking statements may not prove accurate. 17:15.700 --> 17:19.700 And so you can't hold this accountable of what we're talking shit about right now. We can't actually accomplish. 17:19.700 --> 17:27.700 So just, it's not some special disclaimer. It's just kind of sad, actually, because then he's admitting that this is just a sales pitch with a lot of tough talk. 17:27.700 --> 17:31.700 From our lawyers. 17:31.700 --> 17:41.700 Next, my plan for today is to tell you about a seller is technology platform for discovering therapeutic antibodies and how machine learning makes a key part of it. 17:42.700 --> 17:55.700 At the highest level, we at a seller are a tech company. We make long term investments in teams and technology so that we can fast track drug development and we partner with drug developers from large pharmaceutical companies to small biotech startups. 17:55.700 --> 18:00.700 We help them move quickly, reduce their costs and tackle their toughest problems. 18:00.700 --> 18:11.700 We built a modern technology platform for drug development and it ensures that the best science is quickly translated into new therapies so that we can benefit patients. 18:11.700 --> 18:20.700 Our arena for drug discovery is the adaptive immune system. And like all the biology, it's quickly becoming a goldmine for data science. 18:20.700 --> 18:25.700 Within each individual nature is operating at this massively diverse scale. 18:25.700 --> 18:35.700 Every one of us can make billions of different antibodies. It was almost like he kind of slipped there, right? He was going to say a goldmine and then he realized it all the way. 18:35.700 --> 18:42.700 You could see that he knew that was kind of like a double meaning. You know, it's a lot of money and also a lot of data. 18:42.700 --> 18:51.700 The ab in our name of Celera is a nod to these antibodies or abs as we affectionately call them. They're a crucial part of our immune system. 18:51.700 --> 19:04.700 This little green Y shaped symbol underneath represents the antibodies in this talk and it gives you a guarantee you during this entire talk he's not going to stop calling them antibodies is never going to call them abs. 19:04.700 --> 19:09.700 And that is just such a dumb statement. I can't. Anyway, I'm wasting time. 19:09.700 --> 19:15.700 Big idea of the shape of an antibody molecule. 19:15.700 --> 19:25.700 So at any given moment, we've got millions of immune cells making different antibodies and these antibodies form a molecular database based on the state of our health. 19:25.700 --> 19:31.700 They serve sort of as a memory of all the previous infection and disease challenges that we've ever faced. 19:31.700 --> 19:41.700 But one of the big problems in understanding adaptive immunity is the lack of technology to read this database to understand it and to change it. 19:41.700 --> 19:50.700 We can tackle this problem by analyzing the individual immune cells. Each of them produces one of the billions of antibody molecules a person can make. 19:50.700 --> 19:57.700 And every immune cell contains its own DNA code, which describes how to make a potentially therapeutic antibody. 19:57.700 --> 20:04.700 So the solution is to search through the immune system's vast database and find ways to interrogate one at a time. 20:04.700 --> 20:12.700 You have millions of cells that underlie our adaptive immune system. 20:12.700 --> 20:25.700 Appsellors drug discovery platform uses microfluidics, machine learning and other computation and customer robotics and automation to search, decode and analyze the natural immune system at record speed and depth. 20:25.700 --> 20:30.700 The speed and depth of our technology has redefined how antibody drugs are discovered. 20:30.700 --> 20:34.700 We've compressed a process that can take years into just weeks. 20:34.700 --> 20:39.700 And this is kind of giving you a bird's eye bird's eye view of what we do. 20:39.700 --> 20:52.700 It starts by sourcing a natural immune response, which can be in the form of a blood sample from a person or an animal exposed to a target pathogen, or from an animal immunized with some immunogen. 20:52.700 --> 21:01.700 The immune system can actually be directed to make antibodies against any target, such as those important in cancer or other targets that can cause other diseases. 21:02.700 --> 21:08.700 Next, we search the sample using our high throughput single cell screening pipeline. 21:08.700 --> 21:15.700 Here, we examine millions of immune cells to identify hundreds of high potential target specific antibodies. 21:15.700 --> 21:18.700 And this happens in just a matter of days. 21:18.700 --> 21:23.700 We use machine learning and computer vision here in ways I'll describe later. 21:24.700 --> 21:28.700 Computer vision. That's really funny. That's not. 21:28.700 --> 21:33.700 It's automated confocal microscopy and my guess is. But anyway, it's funny. 21:33.700 --> 21:38.700 Situate the genomic profile of the single cell antibodies we find within the broader content. 21:38.700 --> 21:41.700 Oh, my God. I just realized something, Mark. You're not going to believe this. 21:41.700 --> 21:50.700 But remember when Robert Malone was on the Tommy podcast with Hatfield? And I told you, he was on there. 21:51.700 --> 21:58.700 And he said, he said a completely different methodology for how he screened those drugs. 21:58.700 --> 22:05.700 So in one interview or more, one more than one interview, he said that he, it's okay. 22:05.700 --> 22:08.700 You can come through just in more than one interview. 22:08.700 --> 22:19.700 He said that he had made an x-ray crystallography model of the three CL protease and then interface that with all of the known drugs. 22:19.700 --> 22:23.700 And pharmaceuticals in the FDA catalog. 22:23.700 --> 22:33.700 And in another, in that specific Tommy interview, what he said was, is that they used high throughput confocal, 22:33.700 --> 22:42.700 my laser confocal microscopy, which is exactly, exactly what you would use in this scenario and what they're going to describe in five minutes, 22:42.700 --> 22:48.700 which is very, very curious because the two aren't the same. 22:48.700 --> 22:57.700 If you use a computer model of x-ray crystallography of an enzyme and interface that with computer models of different pharmaceuticals, 22:57.700 --> 23:06.700 that's entirely different than using live samples and high throughput laser scanning confocal microscopy, which is certainly how they're doing this. 23:06.700 --> 23:08.700 So that's curious to me. 23:08.700 --> 23:17.700 Next up, the overall immune response, which we can further sample using a process called repertoire profiling, and I'll describe that in more detail later. 23:17.700 --> 23:24.700 The most promising antibodies we find are expressed and further characterized based on approximately 500 different factors. 23:24.700 --> 23:35.700 And again, here we use machine learning, bioinformatics, and advanced data visualization techniques to determine their developability and suitability as drug candidates. 23:36.700 --> 23:44.700 So the result is a set of fully characterized and validated antibodies ready for development as potential therapies. 23:44.700 --> 23:53.700 As a side note, sometimes, when I talk to people outside of epsilon, one of the things they misunderstand is the difference between an antibody and a vaccine. 23:53.700 --> 24:04.700 So vaccines are designed to teach your body to make its own antibodies, but that process can take many weeks, and not everyone can survive an infection for that long, 24:04.700 --> 24:09.700 which is why you typically need to be vaccinated well in advance of your exposure to a disease or a pathogen. 24:09.700 --> 24:10.700 Yeah. 24:10.700 --> 24:13.700 But therapeutic antibodies can give you a shortcut. 24:13.700 --> 24:22.700 They give someone immediate access to a potent antibody long before their immune system could have figured it out, how to make something equally effective. 24:22.700 --> 24:26.700 So next, I'd like to walk you through more of the details of these steps. 24:26.700 --> 24:32.700 And along the way, I'll explain a few more ideas from immunology and also some of our technological innovations. 24:32.700 --> 24:38.700 And as you might imagine, there are many places on this pipeline where machine learning comes in handy. 24:38.700 --> 24:42.700 So I'll talk about those as well. 24:42.700 --> 24:46.700 I mentioned earlier that it all starts with a natural immune response. 24:46.700 --> 24:53.700 So something that's really fascinating to me is that all vertebrates have what's called an adaptive immune system. 24:53.700 --> 24:57.700 It starts to kick in within a week or two weeks of exposure to a pathogen. 24:57.700 --> 25:08.700 And unlike the rest of our body's cells, adaptive immune cells have special tricks to rearrange and mutate their own DNA as they try to create better antibodies. 25:08.700 --> 25:16.700 If you've ever implemented a genetic search algorithm on a computer, it's actually a pretty good analogy for what's going on with these B cells. 25:16.700 --> 25:22.700 Here, the fitness function is how well the resulting antibody binds to the target. 25:22.700 --> 25:29.700 So the B cells, what they're doing is searching for a protein structure that docks with a pathogen and binds to it. 25:29.700 --> 25:34.700 And the search is massively parallel. It's happening all over your body as the B cells divide. 25:34.700 --> 25:42.700 The result of the search, which progresses over the weeks and months following your exposure to a pathogen, is a huge diversity of B cells, 25:42.700 --> 25:45.700 each of which produces its own antibody protein. 25:46.700 --> 25:56.700 But since these B cells are scattered throughout the immune organs and the blood mixed with everything else, getting the right ones is like finding a needle in a haystack. 25:56.700 --> 26:06.700 So to look through the haystack, we developed an assay that contains hundreds of thousands of B cells in tiny isolated chambers on a microfluidic device, the size of a credit card. 26:07.700 --> 26:11.700 So one of the patents will be how they fill these cells with only one cell. 26:11.700 --> 26:18.700 There's probably a process or a robot or a series of solutions, whatever they do to get that. 26:18.700 --> 26:21.700 That would be one of the patented processes here. 26:21.700 --> 26:26.700 One way we can use it is to load individual B cells into the device's chambers. 26:26.700 --> 26:30.700 So here, the B cell is depicted as the green circle inside the chamber. 26:31.700 --> 26:40.700 And alongside the B cell, we can also load these tiny beads that are coated with different target antigen proteins, shown here as gray spheres. 26:40.700 --> 26:46.700 These isolated B cells in the chamber will then secrete their own antibody inside that chamber. 26:46.700 --> 26:56.700 So if the B cell is secreting a good antibody, an antibody that binds to the proteins on the beads, it'll stick to the beads that are coated with the antigen. 26:57.700 --> 27:00.700 Both the beads and the antibodies can be fluorescently tagged. 27:00.700 --> 27:04.700 And this results in a visual signature when the antibodies stick to the beads. 27:04.700 --> 27:08.700 We can pick up this signature using high-throughput fluorescence microscopy. 27:08.700 --> 27:10.700 And just as a side note... 27:10.700 --> 27:14.700 High-throughput fluorescence microscopy. You heard him say it. 27:14.700 --> 27:19.700 That's exactly what Robert Malone said on the Tommy podcast with Hatfield. 27:19.700 --> 27:20.700 I'm sure of it. 27:20.700 --> 27:25.700 Sometimes we also load other kinds of beads coated with proteins we don't want the antibodies to bind to. 27:25.700 --> 27:30.700 And again, whether or not the antibodies are sticking to those beads is also visible in the fluorescent... 27:30.700 --> 27:34.700 No, this is clever. And they would get to narrow things down a lot. 27:34.700 --> 27:38.700 But they're still left with hundreds of antibody candidates that bind their target proteins. 27:38.700 --> 27:45.700 So they could probably repeat this over and over with an ever more specific antigen set in here. 27:45.700 --> 27:50.700 But I don't think he's going to explain that totally here. 27:50.700 --> 27:55.700 So, as I mentioned, there are over 250,000 chambers in a single microfluidic device. 27:55.700 --> 28:03.700 And our high-throughput microscopy system images each chamber at several different wavelengths to create a multi-channel image, 28:03.700 --> 28:07.700 which is depicted on the bottom right in sort of a cartoon format. 28:07.700 --> 28:11.700 I have no doubt in my mind that this works for finding monoclonal antibodies. 28:11.700 --> 28:13.700 I have no doubt in my mind. It's a great idea. 28:13.700 --> 28:16.700 But now what they're doing is they're going to sequence these cells. 28:16.700 --> 28:18.700 Vision model models can help us. 28:18.700 --> 28:24.700 They're going to sequence these cells and then they're going to use those sequences in their informatics. 28:24.700 --> 28:26.700 That's really the trick here. You can see it. 28:26.700 --> 28:28.700 The particular binding profile that we want. 28:28.700 --> 28:32.700 For heavily multiplexed assays with many different types of beads, 28:32.700 --> 28:35.700 humans can't easily keep track of which bead types are binding and which aren't. 28:35.700 --> 28:38.700 So computer vision also enables richer multiplexing. 28:38.700 --> 28:41.700 See, machine vision, that's also just dumb. 28:42.700 --> 28:48.700 It is how you would do it in high-throughput fluorescence microscopy. 28:48.700 --> 28:54.700 You use different wavelengths and then you use a photon detector so your eye isn't seeing it. 28:54.700 --> 28:58.700 And it's using these words to try and bamboozle the audience. 28:58.700 --> 29:01.700 You're absolutely right. He's selling stock right now. 29:01.700 --> 29:07.700 But remember that a lot of how the momentum of the pandemic was created with this kind of stuff before the pandemic. 29:08.700 --> 29:14.700 This kind of momentum. We heard it in the 2019 talks that we watched two days ago where the guy was saying, 29:14.700 --> 29:18.700 he said anti-vaxxers. He said, take your flu shot. 29:18.700 --> 29:23.700 He said antibodies were the solution. He said vaccines were the only way. 29:23.700 --> 29:30.700 He said everything. So it shouldn't be underestimated how on narrative this stuff has always been 29:30.700 --> 29:36.700 and how it will remain on narrative that this technology is necessary to save us from our environment, 29:36.700 --> 29:42.700 from our mother nature. I've got about six minutes and then we're going to use a tonic live on YouTube. 29:42.700 --> 29:49.700 Our computer vision models use popular state-of-the-art architectures for classification, object detection and image segmentation. 29:49.700 --> 29:56.700 And one thing that's really important is they need to be robust and work across a wide variety of assay configurations 29:56.700 --> 30:01.700 and robust to the variance and noise that you typically see in these kinds of biological experiments. 30:02.700 --> 30:09.700 So once we've picked the hits using computer vision, we'll use an automated robotic process to recover them. 30:09.700 --> 30:16.700 And then we analyze the recovered B cells to identify the amino acid sequences of the antibodies they're producing. 30:16.700 --> 30:22.700 So what this lets us do is reproduce samples of the antibody for later characterization and validation. 30:23.700 --> 30:29.700 So one output from our bioinformatics pipeline is the genetic sequence from each B cell. 30:29.700 --> 30:35.700 And we can use this to figure out the amino acid sequences that make up each antibody. 30:35.700 --> 30:39.700 And this table is kind of a sketch of what that data looks like. 30:39.700 --> 30:42.700 So each row here is a single antibody. 30:42.700 --> 30:47.700 And each letter in the row represents an amino acid in the protein sequence. 30:48.700 --> 30:53.700 At the highest level, human antibodies are formed from two distinct amino acid chains. 30:53.700 --> 30:55.700 One is called the heavy chain. 30:55.700 --> 31:01.700 And it's shown here spanning most of the slide, the width of most of the slide, with a dark gray header. 31:01.700 --> 31:05.700 And on the right, there's a light chain with a lighter gray header. 31:05.700 --> 31:10.700 I've actually chopped out many of the heavy chains amino acids and all the amino acids from the light chain 31:10.700 --> 31:12.700 so that this table would fit on the screen. 31:12.700 --> 31:16.700 But what I want you to see is that each chain has a few different regions within it. 31:16.700 --> 31:22.700 The blue regions are called the framework regions and they provide a scaffolding structure for the antibody. 31:22.700 --> 31:25.700 And they vary less across different antibodies. 31:25.700 --> 31:28.700 Whereas the orange regions are known as the CDR loops. 31:28.700 --> 31:32.700 And they're the part of the antibody that actually determines what it's going to bind to. 31:32.700 --> 31:35.700 And so there's an incredibly rich diversity here. 31:35.700 --> 31:43.700 If you remember the idea of the genetic search, this is where most of the point mutations in the immune system search are focused 31:43.700 --> 31:46.700 is on the CDR loops. 31:46.700 --> 31:51.700 So at this point, what we've done is we've gone from an enormous haystack of images 31:51.700 --> 31:56.700 to a smaller but still daunting haystack of amino acid sequences. 31:56.700 --> 32:00.700 And as you might guess, it's hard to just read these sequences directly. 32:00.700 --> 32:04.700 But there's been an explosion of techniques in the field of natural language processing 32:04.700 --> 32:09.700 that fit perfectly onto these kinds of data sets. 32:09.700 --> 32:14.700 So you heard him in the beginning, right? He worked for Google and he did language processing AI models 32:14.700 --> 32:20.700 or machine learning models. And now he's going to apply those to understanding the antibodies. 32:20.700 --> 32:25.700 And what you're going to see is an interesting thing. 32:25.700 --> 32:28.700 And then we're going to let it go. It's like three minutes and then we're done here. 32:28.700 --> 32:34.700 One example, we can approach the complexity of this sequence space using dimensionality reduction. 32:34.700 --> 32:39.700 So what this means is we take the high dimensional amino acid sequences for each antibody 32:39.700 --> 32:42.700 and encode them into a lower dimensional embedding vector. 32:42.700 --> 32:48.700 So what you see here, each point in this plot is a single antibody heavy chain. 32:48.700 --> 32:55.700 And we've projected the sequence space down to just two dimensions so that we can plot the antibodies on the screen. 32:55.700 --> 33:00.700 And each of the three panels here shows the sequences that came from a different donor. 33:00.700 --> 33:05.700 And what's really nice about the way this turned out is that the 2D projection of the sequences 33:05.700 --> 33:08.700 isn't really clustering the donors away from one another. 33:08.700 --> 33:15.700 It could have turned out that the differences between different donors were so large that each donor would land in its own region 33:15.700 --> 33:18.700 of this two-dimensional projection space. But that didn't happen. 33:18.700 --> 33:27.700 Instead, what you see is that each donor's antibodies are well distributed across the entire two-dimensional projection space. 33:28.700 --> 33:32.700 What's cool is that if we color the antibodies using some metric of... 33:32.700 --> 33:42.700 It's not really clear to me what this two-dimensional space is and what the heavy chain U-map and whatever one and zero is. 33:42.700 --> 33:44.700 And so that makes it somewhat confusing. 33:44.700 --> 33:49.700 But let's just assume that they're using some uniform classification. 33:49.700 --> 33:56.700 And you can see that the cluster patterns across these different donors is pretty similar, which is interesting 33:56.700 --> 34:04.700 in that, again, what we saw with epivacs, there are likely certain residues in these proteins 34:04.700 --> 34:11.700 which attract the attention of the immune system for whatever reason being immunogenic, even across donors. 34:11.700 --> 34:22.700 And that should lead you to believe that this lack, almost lack of diversity here is because to a certain extent, 34:22.700 --> 34:31.700 there's a limited palette of foreign and immunogenic sequences that not surprisingly is pretty similar across humans. 34:31.700 --> 34:40.700 I mean, we use different HLA subtypes, but the diversity within that subtype from a given pathogen shouldn't be that different. 34:40.700 --> 34:46.700 What should be different is how what antibody sequence is chosen to represent that portion. 34:46.700 --> 34:55.700 And so it's curious that they cue in on the right on the same epitopes irrespective of whether they have the same HLA subtype. 34:55.700 --> 35:02.700 So what I believe this suggests from the perspective of the other technology that we saw the other day with epivacs 35:02.700 --> 35:09.700 is that the HLA specificity changes certain amino acids in the projected epitope and certain amino acids, 35:09.700 --> 35:14.700 which are known for in the selected B cells and T cells on the other side. 35:14.700 --> 35:19.700 And I should have said that up T cells and B cells on the other side of antigen presentation. 35:19.700 --> 35:24.700 So maybe that probably wasn't a very good explanation because it's no visuals here. 35:24.700 --> 35:36.700 But I think I understand this in a way that I think it makes sense that this works. 35:36.700 --> 35:41.700 I think it's a question of what can these antibodies be used for besides curing cancer. 35:41.700 --> 35:44.700 Like how well they neutralize the virus. 35:44.700 --> 35:51.700 We can see that even across donors, some factors jump out as being hotspots for potential neutralizers. 35:51.700 --> 35:57.700 So, for example, in each panel, there's this cluster of potent red antibodies in the lower left quadrant. 35:57.700 --> 35:59.700 I'll see if I can turn to Mike. 35:59.700 --> 36:02.700 So we don't even know what they stimulated this to, right? 36:02.700 --> 36:05.700 We don't know what the antigen was in this study. 36:05.700 --> 36:08.700 So it's really a vague description of what's going on. 36:08.700 --> 36:17.700 And has somebody said earlier, it's a bit like hypnosis, it's a bit, it's a bit salesy, it's a bit. 36:17.700 --> 36:22.700 It's a bit snake oily in that sense. 36:22.700 --> 36:25.700 This cluster here is what I'm talking about. 36:25.700 --> 36:27.700 It shows up in several of these panels. 36:27.700 --> 36:30.700 Good evening from Pittsburgh, Hong Kong. 36:30.700 --> 36:32.700 So this is exactly what we want to see. 36:32.700 --> 36:40.700 That our sequence embedding vectors are encoding useful information about the properties of the antibodies. 36:40.700 --> 36:46.700 So once we've identified antibodies of interest, first via imaging and then by looking at their sequences, 36:46.700 --> 36:50.700 we express and characterize them using several different assays. 36:50.700 --> 36:55.700 The first thing we want to do is validate that the antibodies bind as we actually expect they would. 36:55.700 --> 37:00.700 And then we have many other assays to measure things like chemical properties, their stability, their affinity, 37:00.700 --> 37:04.700 and the way they bind to our particular antigen. 37:04.700 --> 37:07.700 All this characterization data feeds our machine learning algorithms 37:07.700 --> 37:13.700 and can inform both upstream antibody detection and selection and also downstream protein engineering. 37:13.700 --> 37:18.700 And we continually accumulate more and more of this data as we run these assays. 37:18.700 --> 37:20.700 So make sure you heard that, right? 37:20.700 --> 37:23.700 He just told you a very special thing there. 37:23.700 --> 37:26.700 It's very similar to what EpiVac said. 37:26.700 --> 37:37.700 Annie DeGroote said, excuse me, that they can find those immunogenic epitopes. 37:37.700 --> 37:42.700 But then more importantly, the obvious dual use of that is to insert them into proteins, 37:42.700 --> 37:44.700 to make proteins more immunogenic. 37:44.700 --> 37:46.700 And he basically just said the same thing. 37:46.700 --> 37:48.700 You can use that. 37:48.700 --> 37:57.700 This information of these epitopes and the way they're encoded in antibodies also in protein design. 37:57.700 --> 38:05.700 And so biologics, proteins, protein design, I can't think of very many other things that you would want to design 38:05.700 --> 38:08.700 from the perspective of a vaccine other than immunogenicity. 38:08.700 --> 38:13.700 So controlling where that immunogenicity is on the protein 38:13.700 --> 38:18.700 and where the immune system focuses would be a pretty spectacular art form. 38:18.700 --> 38:24.700 And I think it's very possible that that's the story that's being manipulated here, 38:24.700 --> 38:30.700 that what they did was they told us a story about a sequence they found embedded in that sequence 38:30.700 --> 38:33.700 was a pre-designed immunogen. 38:33.700 --> 38:38.700 Whether or not that immunogen ever went in circulation I think is beyond a doubt not likely. 38:38.700 --> 38:45.700 But whether that immunogen was released as a transfection, as an infectious clone, 38:45.700 --> 38:52.700 with limited spread or with a large quantity over some of these places, that's very possible. 38:52.700 --> 38:58.700 And if it had an immunogenic protein on it, of course that would have generated a lot of the disease states 38:58.700 --> 39:02.700 that were necessary in order to start that panic in those different geographic regions. 39:03.700 --> 39:11.700 This technology to me has so much dual use, and the way that they took us so long to find this, 39:11.700 --> 39:17.700 and once we've found all of this, the way that the work of Mark Gulak and others, 39:17.700 --> 39:28.700 but for me, mainly Mark, has tied in some of the key players of the dissidents into this story. 39:28.700 --> 39:37.700 And one of those important ones, of course, is Robert Malone. 39:37.700 --> 39:42.700 We're both upstream antibody detection and selection, and also downstream protein engineering. 39:42.700 --> 39:47.700 And we continually accumulate more and more of this data as we run these assays, 39:47.700 --> 39:56.700 which means we can feed it back into our ML models and create a virtuous cycle to keep improving them. 39:57.700 --> 40:00.700 So at this point, I've described how we accumulate sort of a mountain. 40:00.700 --> 40:05.700 One of the things that you can imagine, which I just, 40:05.700 --> 40:12.700 I get frustrated when I think this kind of thing because I'm hesitant to say it because of the no virus people. 40:12.700 --> 40:20.700 But if we were to entertain the possibility that coronaviruses are a real RNA shadow in nature, 40:20.700 --> 40:23.700 that occasionally makes people sick all around the world, 40:24.700 --> 40:29.700 and that there's some homology between the yearly waves of coronavirus 40:29.700 --> 40:33.700 because the homology is around the most conserved proteins, 40:33.700 --> 40:36.700 including the RNA-dependent RNA polymerase. 40:36.700 --> 40:42.700 But then they said that there was a novel one, again with this designer immunogen on it, 40:42.700 --> 40:45.700 so that when they transfected people with it, 40:45.700 --> 40:51.700 a naturally occurring pathogen would become dangerous. 40:51.700 --> 40:56.700 And if you wanted to get rid of a large portion of a useless population, 40:56.700 --> 41:02.700 you might say everybody that takes this shot will just be more vulnerable to the immune interaction 41:02.700 --> 41:07.700 with these previously harmless coronaviruses, 41:07.700 --> 41:11.700 which again, according to their mythology, have so much overlap in their proteins 41:11.700 --> 41:15.700 that according to anti-dechrot, or dechrot, 41:15.700 --> 41:20.700 the protein would actually be tolerogenic. 41:20.700 --> 41:27.700 And so that's no good if all of the coronavirus proteins are mimicking human epitopes 41:27.700 --> 41:31.700 so that they generate tolerance, 41:31.700 --> 41:35.700 then you have a real issue because then how do you make a vaccine to that? 41:35.700 --> 41:36.700 You don't. 41:36.700 --> 41:39.700 But you could make a vaccine to it if you designed the spike protein 41:39.700 --> 41:42.700 that you intended to use as a vaccine to be immunogenic 41:42.700 --> 41:47.700 and then lied about it being present in a novel lab league. 41:47.700 --> 41:50.700 And I know I'm going out here on a limb here, but what? 41:50.700 --> 41:54.700 I mean, otherwise I'm repeating myself over and over again. 41:54.700 --> 42:00.700 I think this is the sort of intellectual space you have to explore at this stage, 42:00.700 --> 42:08.700 because if this is the front-facing, public, non-confidential presentation that this guy gives, 42:08.700 --> 42:16.700 then I can anticipate what the behind-the-scenes DARPA DOD presentation is. 42:16.700 --> 42:18.700 That's for sure. 42:18.700 --> 42:21.700 And I can certainly imagine what Dr. Giordano would take with this 42:21.700 --> 42:25.700 and say, well, what we can do with this is a lot. 42:25.700 --> 42:30.700 So to me, that's pretty easy to see. 42:30.700 --> 42:33.700 Anyway, I'm going to let this go for a little while longer, 42:33.700 --> 42:36.700 because Mark might not be ready till 8.30, 42:36.700 --> 42:38.700 so I'm going to go a little while longer. 42:38.700 --> 42:42.700 If he doesn't ping me back, I'll just end in a few minutes anyway. 42:42.700 --> 42:45.700 Data, characterizing the antibodies we find. 42:45.700 --> 42:49.700 But it's likely that there's still too many antibodies to bring to a clinical trial. 42:49.700 --> 42:52.700 So we have to further refine the list. 42:52.700 --> 42:55.700 So we've developed this internal tool, we call it Celium, 42:55.700 --> 42:59.700 to help our scientists make sense of this very high-dimensional data set. 42:59.700 --> 43:01.700 And so that's really the trick, right? 43:01.700 --> 43:03.700 That's what they're selling. 43:03.700 --> 43:08.700 They're doing some pretty basic microfluidic sorting of B cells. 43:08.700 --> 43:12.700 And the actual selling thing, I think, honestly, 43:12.700 --> 43:16.700 after they have all this high-throughput screening of B cells done. 43:16.700 --> 43:18.700 And the main thing that they're selling, 43:18.700 --> 43:22.700 the main thing that they're going to leverage are AI, machine learning, 43:22.700 --> 43:26.700 software stacks that contain patented code, 43:26.700 --> 43:30.700 or patented subroutines, or patented search parameters, yada, yada, 43:30.700 --> 43:34.700 yada, whatever it is, trademark names. 43:34.700 --> 43:39.700 And that's how they layer on the value that they provide to their clients. 43:39.700 --> 43:43.700 That's how they layer on the value that they draw for the royalties 43:43.700 --> 43:46.700 that they're going to charge when they return the data back to those people, 43:46.700 --> 43:49.700 and then they use it to make products and they owe them royalties. 43:49.700 --> 43:52.700 That's the whole model. 43:52.700 --> 43:57.700 And so companies that bring their old monoclonals to them 43:57.700 --> 44:02.700 can launder them through here and generate new monoclonals 44:02.700 --> 44:06.700 to the same target that might be better and then have launder them through 44:06.700 --> 44:09.700 or produce them with this software. 44:09.700 --> 44:17.700 So it's a patentable process that enables the finding of monoclonal antibodies. 44:17.700 --> 44:22.700 And so you just bypassed the antibody patent paradox completely, 44:22.700 --> 44:25.700 and then you did it in Canada, no matter, even better. 44:25.700 --> 44:29.700 See, I think it's a really interesting story that more people, 44:29.700 --> 44:34.700 with more knowledge than I, need to latch onto it, 44:34.700 --> 44:37.700 start to investigate how plausible this is. 44:37.700 --> 44:40.700 And meanwhile, they have Dr. Giordano running around and telling everybody 44:40.700 --> 44:45.700 about all this other stuff that's actually still 50 years on the horizon 44:45.700 --> 44:48.700 if that, where all of this stuff is real and right now 44:48.700 --> 44:52.700 and totally relevant for the pandemic narrative. 44:52.700 --> 44:54.700 So I don't know what to say. 44:55.700 --> 44:58.700 It overlays information derived from the protein sequences, 44:58.700 --> 45:01.700 alongside measurements collected at the wet bench. 45:01.700 --> 45:05.700 So it gives scientists a way to tease apart and understand these relationships. 45:05.700 --> 45:09.700 And we're constantly integrating more powerful ML-backed analysis tools 45:09.700 --> 45:13.700 into Selium to help our scientists understand the antibody landscape 45:13.700 --> 45:15.700 and make better decisions. 45:19.700 --> 45:23.700 So up to now, I've told you about our single cell screening platform 45:23.700 --> 45:27.700 and sort of to recap that, it all starts with that immune response. 45:27.700 --> 45:30.700 And from that immune sample, we screen single B cells in isolation. 45:30.700 --> 45:33.700 We're looking for interesting binding signatures. 45:33.700 --> 45:37.700 And then we recover those B cells and analyze their amino acid sequence. 45:37.700 --> 45:40.700 And finally, we express the best candidates, characterize their properties, 45:40.700 --> 45:42.700 and validate their binding profile. 45:42.700 --> 45:46.700 But because the immune system can produce such a vast diversity of antibodies, 45:46.700 --> 45:52.700 screening even 500,000 cells isn't enough for a complete picture of the immune response. 45:54.700 --> 45:57.700 So in parallel with this single cell screening process, 45:57.700 --> 46:01.700 we can also sequence an even larger sample of the immune cells using a process 46:01.700 --> 46:03.700 called repertoire sequencing. 46:03.700 --> 46:08.700 And this gives us even more sequence data about what the immune system is doing 46:08.700 --> 46:10.700 and the sequences that are present in the sample. 46:10.700 --> 46:12.700 But it comes at a cost. 46:12.700 --> 46:15.700 We get much less information about each individual antibody. 46:15.700 --> 46:21.700 So the single cell process that's depicted in the top row and that I described in detail 46:21.700 --> 46:25.700 tells us exactly which heavy and light chains were paired together 46:25.700 --> 46:27.700 to form a particular antibody. 46:27.700 --> 46:31.700 But the repertoire sequencing process mixes all the heavy and light chains together 46:31.700 --> 46:34.700 so the sequences come to us unpaired. 46:34.700 --> 46:39.700 And it's also harder to look for a very specific binding profile using this technology. 46:41.700 --> 46:45.700 To deal with this, we use bioinformatics and machine learning techniques 46:45.700 --> 46:49.700 inspired by natural language processing to learn features from our single cell antibodies 46:49.700 --> 46:52.700 and find related sequences from the repertoire data. 46:52.700 --> 46:58.700 So here on the left, you can see an inferred lineage relationship between a single cell lead. 46:58.700 --> 47:00.700 This is our antibody of interest. 47:00.700 --> 47:01.700 It's highlighted in green. 47:01.700 --> 47:03.700 And then it's germline parent, which is above it. 47:03.700 --> 47:08.700 And that's a putative ancestor of this cell. 47:08.700 --> 47:13.700 And then some of its single cell descendants that also showed up in the assay, 47:13.700 --> 47:16.700 the single cell screening assay. 47:17.700 --> 47:20.700 But now on the right, what you see is a much deeper lineage tree, 47:20.700 --> 47:24.700 and it includes heavy chains obtained from repertoire sequencing. 47:24.700 --> 47:28.700 This same single cell heavy chain is still shown in green on the right-hand tree, 47:28.700 --> 47:33.700 but now it fits into a much richer set of the heavy chains obtained from the repertoire sequencing. 47:33.700 --> 47:36.700 And this helps us understand how the single cell hits we've isolated 47:36.700 --> 47:39.700 are fitting into the overall immune response, 47:39.700 --> 47:44.700 and to potentially identify even better candidate sequences. 47:45.700 --> 47:47.700 I can freely admit I'm not really following. 47:47.700 --> 47:49.700 So stepping back to the bigger picture of how ML fits into eCelera, 47:49.700 --> 47:53.700 I see it as much less of an end product than as a research and problem-solving tool. 47:53.700 --> 47:57.700 So here machine learning exists to support a never-ending stream 47:57.700 --> 48:02.700 of partner discovery projects and campaigns across the entire scientific pipeline. 48:02.700 --> 48:08.700 We're driving scientific research, so there's often a new twist on every project. 48:08.700 --> 48:12.700 One problem we definitely don't have is running out of our validation and test data. 48:12.700 --> 48:17.700 But what we do constantly worry about is whether our models will generalize into their next deployment. 48:17.700 --> 48:22.700 So we have to make fluid transitions between exploratory data analysis and machine learning 48:22.700 --> 48:25.700 to understand where we are and how we're doing. 48:25.700 --> 48:29.700 Our goal isn't just to automate specific processes or fine-tune models 48:29.700 --> 48:32.700 to improve metrics on canned pre-existing datasets. 48:32.700 --> 48:35.700 eCelera controls the entire discovery pipeline from immunization strategies, 48:35.700 --> 48:38.700 cell screening protocols, imaging equipment, mechatronics, 48:38.700 --> 48:41.700 protein expression, assay development, all of this. 48:41.700 --> 48:44.700 So we have a say in how the datasets are generated, what gets measured, 48:44.700 --> 48:47.700 and which processes can be improved. 48:47.700 --> 48:52.700 Something else about our team that's somewhat unique is that we operate across many different data scales. 48:52.700 --> 48:56.700 Some parts of our pipeline generate terabytes of data relatively cheaply, 48:56.700 --> 49:01.700 whereas other assays are so costly or slow that we only get a handful of data points to work with. 49:01.700 --> 49:08.700 So we have to be creative and make sure we can gracefully jump to the right scale. 49:08.700 --> 49:13.700 I want to spend just a minute recounting a story that everyone at eCelera is very proud to be part of. 49:13.700 --> 49:18.700 So in early 2020, as you all know, the COVID pandemic was starting to spread throughout the world, 49:18.700 --> 49:21.700 and this put our technology through a trial by fire. 49:21.700 --> 49:28.700 Within three days of receiving a sample from one of the first US patrons who had recovered from COVID-19, 49:28.700 --> 49:31.700 we had screened 5.8 million cells. 49:31.700 --> 49:36.700 And 23 days later, we had selected just 24 leads from those 5.8 million. 49:36.700 --> 49:43.700 And within 90 days, through a partnership with Eli Lilly, one of those antibodies was already in human clinical trials. 49:43.700 --> 49:49.700 Bam Lanovab has gone on to become the first potential treatment developed specifically for COVID-19, 49:49.700 --> 49:55.700 and it's approved in more than 10 countries and approximately 400,000 patients have been treated. 49:55.700 --> 49:59.700 It was a lot of work, and we're very proud of this accomplishment. 50:00.700 --> 50:09.700 I'm wondering if you were using just ML based models, or do you use a mixture of mechanistic or biochemical models? 50:09.700 --> 50:14.700 We have a huge range of models, and this is exactly the kind of question that we're exploring at eCelera. 50:14.700 --> 50:20.700 I can't talk about all the different kinds of models we're using, but we are trying to find what, 50:20.700 --> 50:25.700 and that is what our daily life at eCelera is like, is solving these kinds of research problems. 50:26.700 --> 50:33.700 So that's pretty extraordinary, because that's really the kind of bamboozlement that leads to a pandemic. 50:33.700 --> 50:35.700 It's really how they did it. 50:35.700 --> 50:42.700 It's how they sell stock, it's how they sell these bad ideas on the road. 50:42.700 --> 50:49.700 It's making promises that they can't keep, and as they said, forward-looking statements may not be accurate. 50:50.700 --> 50:56.700 And starting to talk with that, and then talking about this biology as if it's all but done, 50:56.700 --> 51:00.700 I have no doubt that there are uses for monoclonal antibodies. 51:00.700 --> 51:09.700 I have no doubt that there are ways that the immune system can be used in this way to produce therapies for things like cancer and other conditions, 51:09.700 --> 51:16.700 but I do not think we are anywhere near the stage where we can usefully augment the memory of the immune system. 51:17.700 --> 51:24.700 And this talk of doing that was, he started it in the beginning, but he didn't say a word about it afterward. 51:24.700 --> 51:38.700 And so I hope what you can see here really plain as day is that this is just a very multifaceted way of doing an end-around on the antibody-patent paradox, 51:39.700 --> 51:50.700 and the idea that antibodies, monoclonal antibodies in particular, have been patented in a way in the past that they can no longer be patented. 51:50.700 --> 52:00.700 And the entire sort of intellectual property space that is monoclonal antibodies has changed drastically in the past few years because of a recent Supreme Court ruling. 52:01.700 --> 52:14.700 And it's possible that that sort of momentum was known for a while because of previous rulings, including the one that Brett Weinstein's father set in on, 52:14.700 --> 52:18.700 that Mark has reported a number of times, Santa Corps versus somebody else. 52:18.700 --> 52:30.700 And so that's really a point where we are, where we can see a play, a play for one of the only things that does work for certain things. 52:30.700 --> 52:45.700 I'm still curious as to whether monoclonal antibodies really made any difference for people with COVID or whether the antibodies themselves can just ramp up an immune response in a way that is effectively useful for anybody that gets monoclonal antibodies. 52:45.700 --> 52:52.700 Because if there's no meaningful amount of virus in your blood, then monoclonal antibodies shouldn't in theory do anything. 52:52.700 --> 52:57.700 And so I'm still trying to figure out what's going on here too. 52:57.700 --> 53:04.700 I don't have all of the things working in my head, but I know for sure I heard Tad Hughes say that they have so many models and we can't talk about them. 53:04.700 --> 53:13.700 And the whole point of having models that aren't validated or having ideas that are patented first and validated later, this is all business. 53:13.700 --> 53:15.700 It's very different than biology. 53:15.700 --> 53:30.700 And a lot of the pandemic biology is based on business biology, like this talk, and not about real proven understood, you know, grassroots, not grassroots, but foundational immunology. 53:31.700 --> 53:36.700 So I think that's what we're really trying to work on here now. 53:36.700 --> 53:53.700 And I'm trying to build a new slide set that will more adequately describe the absolute state of where we are with understanding this and the kind of possibilities that are there from the worst case scenarios to the most ridiculous ones. 53:54.700 --> 54:02.700 But I think in general, it's a very good place to start for everybody from the perspective of if you've never heard this before. 54:02.700 --> 54:22.700 Or if you're trying to tell somebody something that they didn't expect to hear, you should start with the idea that algorithms and the NIH and the NIAID and DOD and everybody involved in the world public health space has had an impetus 54:22.700 --> 54:33.700 and a notion in their head that pandemics have potential and that potential can be found in mother nature. 54:33.700 --> 54:38.700 If you go looking for it, it can be extracted from mother nature using cell culture. 54:38.700 --> 54:50.700 It can be extracted from mother nature using animal passage and it can even be kind of woven together using genetic techniques to make viruses that maybe mother nature herself never would have come up with. 54:50.700 --> 55:10.700 And this combination of mythologies is being used to convince everybody that there's so much danger from a pandemic and that digital IDs make sense that mandatory vaccinations make sense and that health freedom is really a thing of the past. 55:11.700 --> 55:18.700 And they most importantly want our children to believe that. So that's why we really need to be outspoken and we need to act. 55:18.700 --> 55:27.700 We can't just wait for everybody else to fix. We can't wait for people to wake up. Everyone needs to wake up and you need to demonstrate that you're awake. 55:27.700 --> 55:36.700 And so you need to see this picture for what it is. The all-cause mortality is in light blue and that is the graph that they very rarely showed us. 55:36.700 --> 55:47.700 You can see this graph sometimes in the UK but in America they never showed it to us and more importantly they never showed us the change in the deaths due to pneumonia. 55:48.700 --> 55:57.700 And if you just look at this graph and see the middle color blue here on here on here on here the same number of people are dying of pneumonia. 55:57.700 --> 56:08.700 That's this line right here. And that same number of people dying of pneumonia also represents a huge number of people that are having pneumonia even going to the hospital with it and not dying. 56:09.700 --> 56:22.700 And so there is a huge potential for an increase in all-cause mortality due to pneumonia alone if you just change the way it's treated or prevent its treatment. 56:22.700 --> 56:32.700 And for quite some time now I have been arguing that that is one of the primary sources of this limited excess deaths. 56:32.700 --> 56:45.700 That signal was confirmed by Denny Rancor last year and the year before and shown that the all-cause mortality is not correlated with a spreading pathogen. 56:45.700 --> 56:51.700 It stops at borders and more importantly it's correlated with the income of the location. 56:51.700 --> 56:58.700 It can be also correlated with a geographic location. It doesn't cross state borders. 56:58.700 --> 57:02.700 It doesn't cross country borders. It's pathetic. It's the protocols. 57:02.700 --> 57:15.700 And the way that they did it was they changed those protocols with respect to pneumonia by using the implication of a novel virus and the idea that you could test for it if you had a test. 57:15.700 --> 57:22.700 And if you remember in 2020 we didn't have a test in America until March or April, maybe even April or May. 57:22.700 --> 57:29.700 And so a lot of the COVID that was actually in New York City was presumed COVID. Not tested COVID but presumed COVID. 57:29.700 --> 57:35.700 And so that's also a big problem ladies and gentlemen. A huge problem. 57:35.700 --> 57:50.700 And I think that the biology of RNA and the biology of RNA replication as it is drawn best by them means that a natural coronavirus swarm can sustain a pandemic and that's why we have never had one. 57:50.700 --> 58:00.700 That's why SARS burnt out. That's why mayors burnt out even when you make a clone and you release it in China even when you make a clone and you release it in the Middle East. 58:00.700 --> 58:05.700 It's not going to go anywhere. And the clone is a best case scenario. 58:05.700 --> 58:19.700 And that's something that I haven't really made very clear but a clone is the best case scenario for transmission because a clone is millions of copies of the RNA in complete form. 58:20.700 --> 58:31.700 Whereas any other form of the natural virus is a swarm, mostly in competent particles, hundreds of thousands of times more subgenomic RNAs than full genomes. 58:31.700 --> 58:37.700 And so if you don't have very full genomes and all of them are different and many of them are replication and competent. 58:37.700 --> 58:48.700 And then it's obvious that a natural swarm can't sustain a pandemic but if you released a clone in several places it would appear as though a pandemic was underway. 58:48.700 --> 59:00.700 And that high homology between all of those sequences would be your excuse and also would be the magic that would fool all of those molecular biologists around the world to believe there really was an ongoing pandemic. 59:00.700 --> 59:13.700 Because heretofore the identical RNA sequence of a virus has never been found simultaneously in multiple places in the world at the same time. Never. 59:14.700 --> 59:27.700 And so they're using this mythology to invert the rights and individual sovereignty of your children into basic granted permissions. 59:27.700 --> 59:31.700 They want you to carry an ID and ask for permission to go everywhere. 59:31.700 --> 59:39.700 And unfortunately we have been slow rolled into this narrative when a lot of these people could have woken up in 2020. 59:39.700 --> 59:43.700 Mostly didn't. Here at Fund in Bosch was nowhere to be found. 59:43.700 --> 59:45.700 Robert Malone was nowhere to be found. 59:45.700 --> 59:52.700 Brett Weinstein was wearing a bandana and isolating all through 2020. 59:52.700 --> 59:59.700 And pushing a drastic lab leak scenario very early on. 59:59.700 --> 01:00:08.700 So all of these individuals that we've been trying to investigate are responsible for this illusion of consensus that we have to find out where this virus came from. 01:00:09.700 --> 01:00:14.700 And that the virus did most of it is one of the things that people are still insistent of. 01:00:14.700 --> 01:00:20.700 And that's where you can just see the liars right away when they emphasize the virus still in 2023. 01:00:20.700 --> 01:00:23.700 I mean, give it a rest already. 01:00:23.700 --> 01:00:31.700 Whatever bio weapon was released in 2020 is not represented here now in 2023. That's just absurd. 01:00:32.700 --> 01:00:40.700 And the idea that they're still making that argument in light of all of the biology that we brought out on Giggle Home. It's just sad, really. 01:00:40.700 --> 01:00:48.700 If there's anything going on in the brain, if there's anything going on with amyloidosis or anything like that, it's going to be from transfection. 01:00:48.700 --> 01:01:01.700 Because transfection is the use of synthetic modified RNA to express foreign proteins in your body, and they can't control where it goes, as Peter Cullis told us the other night. 01:01:01.700 --> 01:01:13.700 And so that is a much better, much finer recipe for all of these protein misregulations than a released coronavirus circulating the world is. 01:01:14.700 --> 01:01:26.700 And least of all, because the released coronavirus could never have the fidelity to sustain and keep a hold of all these magic epitopes that supposedly are going around the world. It's just not possible. 01:01:26.700 --> 01:01:32.700 And all these people who say that it is can't produce any papers that show that it is. 01:01:32.700 --> 01:01:39.700 The only papers that are available are papers that make the exact argument that I'm making, which is incompetent fractions. 01:01:39.700 --> 01:01:50.700 It is a genetic swarm, and these two things result in a biology that is different than what they have portrayed on television over the last three years. 01:01:50.700 --> 01:01:56.700 But in order for them to get away with this, they needed to change the way we thought about all of this stuff. 01:01:56.700 --> 01:02:00.700 And they needed to change the way we think about the cause of respiratory disease. 01:02:00.700 --> 01:02:06.700 And they needed to completely bamboozle with us about all cause mortality in America. They never said once. 01:02:06.700 --> 01:02:13.700 That between 55 and 65,000 Americans are expected to die every week. 01:02:13.700 --> 01:02:21.700 They never made any reference to all cause mortality of being close to 3 million per year. 01:02:21.700 --> 01:02:29.700 And so even as they were inverting and substituting and driving up opioid deaths and blaming it all on COVID, 01:02:29.700 --> 01:02:39.700 they never took the time to frame these numbers in the context of all cause mortality because their intention was to make it seem like there was a novel cause of death. 01:02:39.700 --> 01:02:42.700 Something went from zero to a hundred. 01:02:42.700 --> 01:02:58.700 When in reality they were just swapping things around and there wasn't any change except for in the places where they were managing to convince hospitals to change their protocols and doctors to change their protocols. 01:02:58.700 --> 01:03:05.700 And so they ventilated people to prevent spread and killed many. They used remdesivir, medazolam, and they didn't treat pneumonia. 01:03:05.700 --> 01:03:15.700 It's very simple. Three pills were removed from the drawer and everything else was an illusion of consensus. 01:03:15.700 --> 01:03:19.700 All these people agreeing can fool you just like an ash conformity experiment. 01:03:19.700 --> 01:03:25.700 They have fooled us into trying to figure out whether it was a laboratory or a bad cave virus zoonosis. 01:03:26.700 --> 01:03:34.700 In these scenarios, lockdowns and emergency use authorizations caused some excess deaths, but the millions were killed by a novel virus. 01:03:34.700 --> 01:03:39.700 In these scenarios we've defeated epidemics in the past with vaccination. 01:03:39.700 --> 01:03:43.700 In this scenario, novel coronaviruses can jump species in pandemic. 01:03:43.700 --> 01:03:47.700 In this scenario, PCR false positives are very rare. 01:03:47.700 --> 01:03:49.700 Asymptomatic spread is real. 01:03:49.700 --> 01:03:56.700 And we spend money studying viruses, including gain of function experiments that can generate pandemic potential. 01:03:56.700 --> 01:04:00.700 This is the TV scenario one through three. 01:04:00.700 --> 01:04:09.700 The real scenario I believe is that there was a conflated background signal and what that conflated background signal was is not necessarily my job to find out, 01:04:09.700 --> 01:04:17.700 but it could have been the background signal of coronaviruses or whatever they are in reality if their exosomes or whatever. 01:04:18.700 --> 01:04:30.700 And it could also be the combination of that background signal could also be the RNA signals that are present naturally in our nasal passages all the time. 01:04:30.700 --> 01:04:37.700 And so they could be human sequences, bacterial sequences, fungal sequences, whatever. 01:04:37.700 --> 01:04:45.700 And as long as there's sufficient overlap with the sequence that they're looking for, with their primers, the N protein or the RNA, 01:04:45.700 --> 01:04:50.700 dependent RNA polymerase or whatever they say they're using for their, it's ultimately down to the primers. 01:04:50.700 --> 01:04:52.700 It's not about what it's aimed at. 01:04:52.700 --> 01:05:04.700 If they choose primers which are not exquisitely specific for the target gene and overlap with many of the other background, 01:05:04.700 --> 01:05:12.700 RNA and DNA that's known to be present in your nose or in your saliva, then a false positive is not a false positive. 01:05:12.700 --> 01:05:19.700 You're getting a positive and an amplicon is being amplified, but it's just not the target amplicon that they said it was. 01:05:19.700 --> 01:05:24.700 And so now very quickly you roll out a bunch of these things like we did in America. 01:05:24.700 --> 01:05:32.700 There were 250 different products called PCR tests, 250 products. 01:05:32.700 --> 01:05:35.700 I mean, think about that. 01:05:35.700 --> 01:05:36.700 And so it doesn't really matter. 01:05:36.700 --> 01:05:37.700 And I've said this a long time. 01:05:37.700 --> 01:05:41.700 It doesn't really matter whether it was a leak, a lease, a release. 01:05:41.700 --> 01:05:42.700 It's all lies. 01:05:42.700 --> 01:05:44.700 They've been lying about it. 01:05:44.700 --> 01:05:51.700 And once you realize that they're lying about it and you realize that the protocols were murder and transfection is in medicine, 01:05:51.700 --> 01:05:57.700 then how you divvy up this, the cause and effect here doesn't really matter if you know the protocols were murder. 01:05:57.700 --> 01:06:03.700 There's hardly anything left for a particular ravenous virus to do anything with. 01:06:03.700 --> 01:06:09.700 There's no reason to even have it in the story, quite honestly, because there was so much terrible things, 01:06:09.700 --> 01:06:13.700 so many terrible things done with regards to protocols and treatments. 01:06:13.700 --> 01:06:18.700 And so infectious clones released in Iran and Wuhan, sure, why not? 01:06:18.700 --> 01:06:22.700 A transfection agent released somewhere in Iran and Wuhan, sure, why not? 01:06:22.700 --> 01:06:23.700 Whatever you want to call it. 01:06:23.700 --> 01:06:25.700 But this isn't the right answer. 01:06:25.700 --> 01:06:27.700 And this probably is. 01:06:27.700 --> 01:06:29.700 That's really, I really think that's where we are. 01:06:29.700 --> 01:06:32.700 And again, I will keep saying this over and over again. 01:06:32.700 --> 01:06:34.700 Let's pay attention to what people talk about. 01:06:34.700 --> 01:06:43.700 If they're not all going back to the beginning and pointing out the depth and the breadth of the fraud that took place in 01:06:43.700 --> 01:06:52.700 2020 and early 2021 to assure that warp speed would result in lots of people being vaccinated right after 01:06:52.700 --> 01:06:58.700 Joe Biden was elected, then these people aren't being honest with you. 01:06:58.700 --> 01:07:02.700 If they're not looking into Jessica Hockett's data, they're not being honest with you. 01:07:02.700 --> 01:07:08.700 If they're not looking into Denny Rancour's data, they're not being honest with you. 01:07:08.700 --> 01:07:16.700 If they're not aware of the fact that the same thing that Jessica Hockett found in New York was also found in Italy, 01:07:16.700 --> 01:07:18.700 they're not being honest with you. 01:07:18.700 --> 01:07:24.700 If you haven't seen that what Jessica Hockett found in New York is almost so basically found in Chicago, 01:07:24.700 --> 01:07:26.700 then people aren't honest with you. 01:07:26.700 --> 01:07:36.700 If people aren't sharing the fact that the antibody patent paradox case actually occurred during the pandemic 01:07:36.700 --> 01:07:43.700 and that all of these companies that seem to be bypassing or are doing an end-around on the antibody patent paradox 01:07:43.700 --> 01:07:49.700 and that intellectual property space all have a really weird red thread of Robert Malone, 01:07:49.700 --> 01:07:56.700 including a lot of the Canadian companies, including the technology and interacting with some of these companies 01:07:56.700 --> 01:08:00.700 for many, many years, people aren't being honest with you. 01:08:00.700 --> 01:08:07.700 They're talking about something else, talking about something else and asking the wrong questions, 01:08:07.700 --> 01:08:12.700 tricking you into asking the wrong questions, and there aren't too many more questions to ask really. 01:08:13.700 --> 01:08:15.700 Except why haven't we stopped this train? 01:08:18.700 --> 01:08:24.700 And the reason why is because they want our data, yes they do, they would like us to put sensors in our skin 01:08:24.700 --> 01:08:27.700 and all this other stuff, and more importantly they want our kids to do it. 01:08:27.700 --> 01:08:31.700 Remember, I think this is a long game, it's for all the marbles and I don't think they need us to do it. 01:08:31.700 --> 01:08:34.700 I don't even know if they need us to be around before they do it. 01:08:34.700 --> 01:08:40.700 It could be that they're really aiming at my son's kids, your kids, kids. 01:08:41.700 --> 01:08:47.700 And it's that long of a plan, like a 50-year plan, it's not a 10-year plan or a 20-year plan. 01:08:47.700 --> 01:08:50.700 Oh, it's 8.30, I got to get out of here. 01:08:50.700 --> 01:08:53.700 Ladies and gentlemen, intramuscular injection of any combination of substances 01:08:53.700 --> 01:08:55.700 with the intent of augmenting the immune system is dumb. 01:08:55.700 --> 01:08:57.700 Transfection is not immunization. 01:08:57.700 --> 01:09:00.700 Please stop all transfections in humans. 01:09:00.700 --> 01:09:06.700 And I apologize for kind of an impromptu improvised stream here. 01:09:06.700 --> 01:09:10.700 I know I'm usually a little more organized, but I wanted to do something short, 01:09:10.700 --> 01:09:14.700 and then Mark gave me an extra half an hour, so I went a little longer than I should have. 01:09:14.700 --> 01:09:16.700 Make sure you follow Mark, make sure you go find him. 01:09:16.700 --> 01:09:20.700 He's on YouTube right now, I believe, so I might go look for that. 01:09:20.700 --> 01:09:24.700 I might go look for that link and drop it in right here. 01:09:24.700 --> 01:09:26.700 See how I can find it. 01:09:26.700 --> 01:09:33.700 There we go. 01:09:33.700 --> 01:09:41.700 There it is. 01:09:41.700 --> 01:09:45.700 I'll be over here in a little while. 01:09:45.700 --> 01:09:53.700 Thanks, guys, for joining me. 01:09:53.700 --> 01:09:58.700 Yep, thanks very much for joining me, everybody, and I will see you again tomorrow for another show. 01:09:58.700 --> 01:10:03.700 Hopefully my voice will still sound okay. 01:10:16.700 --> 01:10:17.700 What was that? 01:10:17.700 --> 01:10:20.700 Oh, that's him, he's starting. 01:10:20.700 --> 01:10:24.700 Oh, see you guys. 01:10:24.700 --> 01:10:33.700 Take care. 01:10:33.700 --> 01:10:36.700 Make sure you go over to Mark. 01:10:36.700 --> 01:10:40.700 Go over to Mark's show, say hi to him for me. 01:10:40.700 --> 01:10:44.700 Let's see if we can get his viewers up to 100 before he goes to sleep. 01:10:44.700 --> 01:10:49.700 Thanks for joining me, guys, I'll see you tomorrow.